A166
Pill imprint A166 has been identified as Trimethobenzamide hydrochloride 250 mg.
Trimethobenzamide is used in the treatment of nausea/vomiting and belongs to the drug class anticholinergic antiemetics. FDA has not classified the drug for risk during pregnancy.
Trimethobenzamide 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Trimethobenzamide hydrochloride Images
- Imprint:
-
A166
- Strength:
- 250 mg
- Color:
- Blue
- Availability:
- Prescription only
- Drug Class:
- Anticholinergic antiemetics
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Amide Pharmaceutical Inc.
Advertisement
More Trimethobenzamide Hydrochloride resources
- Trimethobenzamide (Wolters Kluwer)
- Trimethobenzamide Solution (Wolters Kluwer)
- trimethobenzamide (Cerner Multum)
- Arrestin (Micromedex) - Includes Dosage Information
- Stemetic (Micromedex) - Includes Dosage Information
- Tribenzagan (Micromedex) - Includes Dosage Information
- trimethobenzamide (Micromedex) - Includes Dosage Information
- trimethobenzamide Intramuscular (Micromedex) - Includes Dosage Information
- Trimethobenzamide Hydrochloride (AHFS DI)
- Tigan Injection (FDA)
- Trimethobenzamide (FDA)
- Trimethobenzamide Capsules (FDA)
- Trimethobenzamide Hydrochloride (Wolters Kluwer)
Search Again
